Hostname: page-component-84b7d79bbc-rnpqb Total loading time: 0 Render date: 2024-07-27T18:23:05.642Z Has data issue: false hasContentIssue false

Question-and-Answer Session

Published online by Cambridge University Press:  07 November 2014

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Expert Panel Supplement
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Fava, M, Rush, AJ, Alpert, JE, et al.Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry. 2008;165(3):342351.CrossRefGoogle ScholarPubMed
2.Candy, M, Jones, L, Williams, R, Tookman, A, King, M. Psychostimulants for depression. Cochrane Database Syst Rev. 2008;(2):CD006722.Google Scholar
3.Masand, PS, Tesar, GE. Use of stimulants in the medically ill. Psychiatr Clin North Am. 1996;19(3):515547.Google Scholar
4.Scheffer, RE, Kowatch, RA, Carmody, T, Rush, AJ. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry. 2005;162(1):5864.Google Scholar
5.Nierenberg, AA, Miyahara, S, Spencer, T, et al, and the STEP-BD Investigators. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005;57(11):14671473.CrossRefGoogle ScholarPubMed